Grove AI ensures reliable clinical trial recruitment with Hamming

In clinical trials, every interaction matters. A missed eligibility question or wrong information can disqualify a participant or, worse, put patient safety at risk. Grove AI needed testing as rigorous as its regulatory environment. With Hamming, the team can:

• Monitor call quality and keep a high standard of patient care
• Stay HIPAA compliant while giving patients accurate information
• Check how Grace handles complex medical terminology and patient conversations
• Catch compliance issues before they reach production

Clinical trial recruitment runs under strict regulatory oversight. Every patient interaction must be documented, every eligibility question asked correctly, and every piece of medical information handled to HIPAA standards. Manual QA could not keep pace with call volume.

Before Hamming, the Grove team spent hours a day reviewing call recordings. Even with dedicated QA staff, they could sample only 5 to 10% of calls, and critical compliance issues sometimes went unnoticed until a research partner or regulator flagged them.

The stakes were high. One instance of Grace sharing wrong trial information or failing to verify a patient's identity could bring regulatory action, damage partner relationships and, most of all, put patients at risk.

• 5 to 10% coverage. Manual QA reviewed a fraction of calls, leaving compliance gaps.
• Regulatory risk. Undetected issues could draw FDA scrutiny or IRB concerns.
• Partner trust. Pharmaceutical sponsors expected thorough quality documentation.
• Patient safety. Wrong medical information could harm participants or invalidate trials.

Grove AI evaluated several testing platforms and found most lacked the healthcare capabilities it needed. Hamming's HIPAA-compliant infrastructure, medical terminology testing, and compliance reporting made it the clear choice.

Scenarios that probe healthcare edge cases, like patients volunteering medical history when they should not, set Hamming apart from general-purpose testing tools.

• HIPAA-compliant infrastructure designed for healthcare
• Medical terminology testing for accurate patient communication
• Automated compliance reports that satisfy partner audits
• 100% call coverage instead of sampling-based QA
• Real-time alerts that catch issues before they reach patients

Grove AI moved from reactive compliance management to proactive quality improvement. Partner audits that took weeks of preparation now take hours, with reports generated automatically.

Most importantly, patient safety improved. With every call covered, the team catches issues immediately. The 97% patient satisfaction rate reflects good agent performance and the confidence of knowing every interaction is monitored.

Grove AI is expanding Grace to support more complex, multi-stage clinical trials and more therapeutic areas, and with Hamming's testing in place it is rolling out to new pharmaceutical partners faster.

The team is also using Hamming's analytics to find interaction patterns that improve Grace's conversations while keeping strict compliance standards.